Clinical Trial Detail

NCT ID NCT03007147
Title Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Children's Oncology Group
Indications

acute lymphoblastic leukemia

Therapies

Pegaspargase

Methotrexate

Leucovorin

Cytarabine

Mercaptopurine

Thioguanine

Vincristine Sulfate

Cyclophosphamide

Imatinib

Ifosfamide

Dexrazoxane

Daunorubicin

Dexamethasone

Methylprednisolone

Etoposide

Prednisolone

Doxorubicin

Age Groups: adult child

No variant requirements are available.